NSE · AI Signal & Stock Analysis · Neutral
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for MARKSANS is Neutral → (extreme move); technical trend down-trend; trading at ₹243.30 (-1.14% today); neutral (RSI 40).
Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Extreme move |
|---|---|
| Technical trend | Down-trend (since 2026-07-21) |
| Price | ₹243.30 |
| Change today | -1.14% |
| RSI (14) | 39.60 |
| Relative volume | 0.16 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹15,090 Cr |
| P/E | 29.18 |
| Cap category | Mid Cap |
| 52-week high | -12.3% away |
| 52-week low | +55.1% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - General |
As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for MARKSANS (Marksans Pharma Limited) is Neutral with a extreme move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
MARKSANS's RSI is neutral (RSI 40). A reading above 70 is typically overbought and below 30 oversold.
MARKSANS is trading about 12% below its 52-week high and 55% above its 52-week low as of Aug 14 2026, 6:50 PM.
MARKSANS's market capitalisation is ₹15,090 Cr as of Aug 14 2026, 6:50 PM.
MARKSANS is classified under Drug Manufacturers - General in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.